[caption id="attachment_69270" align="aligncenter" width="500"]
Photo by ThisIsEngineering[/caption]
Over the past decade, artificial intelligence (AI) and machine learning (ML) have been hailed as game-changers across multiple industries, and healthcare is no exception. From diagnostic imaging to personalized treatments, AI is transforming how we understand and treat disease. Among the most promising areas is clinical research—where AI and ML are touted as tools to make trials faster, smarter, and more efficient.
But as the buzz around these technologies grows, so does skepticism. Are we really witnessing a revolution in clinical trials, or is much of the talk around AI still more hype than reality?
Photo by ThisIsEngineering[/caption]
Over the past decade, artificial intelligence (AI) and machine learning (ML) have been hailed as game-changers across multiple industries, and healthcare is no exception. From diagnostic imaging to personalized treatments, AI is transforming how we understand and treat disease. Among the most promising areas is clinical research—where AI and ML are touted as tools to make trials faster, smarter, and more efficient.
But as the buzz around these technologies grows, so does skepticism. Are we really witnessing a revolution in clinical trials, or is much of the talk around AI still more hype than reality?